Eric Luellen

Eric Luellen

Chief Executive Officer

Bioinformatix LLC


About Me

Eric Luellen is an American technology and serial social entrepreneur with 20 years experience founding, leading, and growing technology related companies. He, or the companies he has led, have been involved with artificial intelligence, software development, systems integration, and consulting including bioinformatics, predicative analytics, data mining, data warehousing, and custom application development in the fields of medicine, education, and telecommunications. Mr. Luellen was raised in a small town in western Pennsylvania. He received a bachelor of arts degree in liberal arts, concentrating in economics, at the American University, and completed a fellowship in e-commerce at the University of Pennsylvania's Wharton School of Business. He earned diplomas in various fields of business, finance, or negotiations at: Harvard Law School's Program on Negotiations (5), MIT's Sloan School of Business (3), Columbia School of Business (1), Caltech's Industrial Relation Program (1), and a separate management program at the Wharton School. From 2006 to 2008, Mr. Luellen completed studies in environmental and medical sciences, and in 2015 in medical genomics, virology and immunology at Harvard University. He is currently pursuing a Master of Science degree in health informatics at Northwestern University. Eric Luellen enjoys adventure travel and, to date, has traveled to Anguilla, Austria, Bahamas, Belgium, Bermuda, Bolivia, Brazil, Canada, Costa Rica, Czech, Denmark, Egypt, France, Germany, Iceland, Indonesia, Italy, Mexico, Netherlands, Northern Ireland, Peru, Puerto Rico, Saba, Singapore, St. Martin, Switzerland, Thailand, US Virgin Islands, and the United Kingdom. He aspires to make it to 100. Mr. Luellen is an Eagle Scout (1985) and black belt in Isshinryu karate. He is also an Advanced Open Water Diver by the Professional Association of Diving Instructors (PADI). He has two daughters.


About the company

Bioinformatix applied artificial intelligence (AI) to medication non-adherence, pharmacovigilance, and care coordination by designing and developing an operational intelligence (OI) Cloud-based platform accessible via any Internet-enabled device (e.g., Smartphone, iPads, etc.) for patients, healthcare providers, pharmaceutical companies, and national health services using complex event processing (CEP).  Wherever real-time insights into patient behavior has the greatest value, AI-OI delivers that information to the people who need to know, when they need to know it, to modify the patients’ behaviors and maximize public health surveillance and monitoring. For patients, this means having a smartphone reminder system for their whole medication regimen that is patient-centric, meaning the system reminds them when they need it in the communication mode they prefer (e.g., call vs. email vs. SMS text vs. direct messaging) different priorities (e.g., call my mobile phone about heart

Contact Information


Boston, Massachusetts